Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Autolus Therapeutics Plc ADR (NQ: AUTL ) 3.900 -0.410 (-9.51%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Autolus Therapeutics Plc ADR < Previous 1 2 3 Next > A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts June 17, 2024 Via Benzinga Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget June 13, 2024 Since wealth without health is utterly meaningless, investors may have some confidence with these biotech stocks to buy. Via InvestorPlace Crude Oil Gains 1%; GameStop Shares Plunge May 17, 2024 Via Benzinga Exposures Fossil Fuels Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 17, 2024 Via Benzinga Breaking Down Autolus Therapeutics: 4 Analysts Share Their Views March 18, 2024 Via Benzinga Autolus Therapeutics's Earnings Outlook March 13, 2024 Via Benzinga Analyst Expectations for Autolus Therapeutics's Future December 13, 2023 Via Benzinga AUTL Stock Earnings: Autolus Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 17, 2024 AUTL stock results show that Autolus Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday May 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session April 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 20, 2024 Via Benzinga Where Autolus Therapeutics Stands With Analysts June 02, 2023 Via Benzinga Preview: Autolus Therapeutics's Earnings May 03, 2023 Via Benzinga The Latest Analyst Ratings for Autolus Therapeutics April 28, 2023 Via Benzinga Earnings Outlook For Autolus Therapeutics March 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session March 15, 2024 Via Benzinga Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga Chart Of The Day: Autolus Therapeutics - Effective Cancer Treatments January 12, 2024 Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. Via Talk Markets 12 Health Care Stocks Moving In Wednesday's After-Market Session December 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 28, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 15, 2023 Via Benzinga Autolus Therapeutics' Obe-Cel's Shows Compelling Safety Over Gilead's Drug For Acute Lymphoblastic Leukemia August 17, 2023 Truist has raised the price target for Autolus Therapeutics PLC (NASDAQ: AUTL) from $6 to $9 Via Benzinga 3 Top Penny Stock Picks You Haven’t Heard Of June 14, 2023 Here are three penny stock picks investors likely haven't heard of, but probably should keep on the radar as speculative options. Via InvestorPlace Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 15, 2023 Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 15, 2023 Via Benzinga Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday March 08, 2023 HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75 on... Via Benzinga Dow Tumbles 100 Points; Silver Rises Over 2% December 09, 2022 U.S. stocks traded mostly lower toward the end of trading with the Dow Jones dropping 100 points on Friday Via Benzinga US Stocks Turn Higher; Nasdaq Rises 40 Points December 09, 2022 U.S. stocks traded slightly midway through trading with the Nasdaq gaining over 40 points on Friday Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 09, 2022 Via Benzinga Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session December 09, 2022 Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.